A pervasive mechanism for analgesia: Activation of GIRK2 channels

Yuri A. Blednov, Markus Stoffel, H. Alva, +1

Proceedings of the National Academy of Sciences

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

Hiddo J.L. Heerspink, C. David Sjöström, Niels Jongs, +414

European Heart Journal

Deletion of the α1 or β2 Subunit of GABAAReceptors Reduces Actions of Alcohol and Other Drugs

Yuri A. Blednov, Sungwon Jung, H. Alva, +4

Journal of Pharmacology and Experimental Therapeutics

GABAA Receptor α1 and β2 Subunit Null Mutant Mice: Behavioral Responses to Ethanol

Yuri A. Blednov, Danielle Walker, H. Alva, +3

Journal of Pharmacology and Experimental Therapeutics

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Hiddo J.L. Heerspink, David Z.I. Cherney, Douwe Postmus, +423

Kidney International